Skip to main content

1 minute readMarch 28, 20229:58 PM UTCLast Updated ago

U.S. FDA approves Novo Nordisk's diabetes drug Ozempic in 2 mg dose

Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS/Jacob Gronholt-Pedersen/File Photo

March 28 (Reuters) - Novo Nordisk (NOVOb.CO) said on Monday the U.S. Food and Drug Administration has approved a higher dosage of 2 mg of Ozempic for the treatment of adults with type 2 diabetes.

Ozempic is now approved in the United States in doses of 0.5 mg, 1 mg and 2 mg, the company said.

Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.

Read Next

Future of HealthcategoryU.S. CDC still looking at potential stroke risk from Pfizer bivalent COVID shot, article with image2:27 AM UTC
WorldcategoryAnti-abortion protesters break into Walgreens AGM meeting room, article with image1:13 PM UTC . Updated undefined ago
COVID-19categoryU.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld, article with imageJanuary 26, 2023
Healthcare & PharmaceuticalscategoryExclusive: EU may pay more for Pfizer COVID shots in return for lower volume, article with gallery12:57 PM UTC . Updated undefined ago

Healthcare & Pharmaceuticals

FDA advisers recommend using same strain for initial COVID vaccine and boosters, article with imageRegulatorycategory · January 26, 2023
Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of using the same coronavirus strain for the initial COVID-19 vaccine doses and the boosters, to simplify the vaccination regimen in the United States.
MarketscategoryJuul in deal talks with three tobacco giants - WSJ, article with imageJanuary 26, 2023
Product LiabilitycategoryFDA classifies recall of Getinge's heart devices as most serious, article with galleryJanuary 26, 2023
RegulatorycategoryU.S. FDA joins global regulators probing tainted overseas cough syrup, article with galleryJanuary 25, 2023
Healthcare & PharmaceuticalscategoryRoche launches new test to detect fast spreading Omicron sub-variant, article with imageJanuary 26, 2023